Study of Radiation Therapy in Combination With Darolutamide + Degarelix in Intermediate Risk Prostate Cancer
Clinical trial NCT04176081 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT04176081
- Sponsor
- University Health Network, Toronto
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-02
- Primary completion
- 2028-12-01
- Enrollment
- 208
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.